The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Endocrine therapy resistance (ETR) in hormone receptor-positive, HER2-negative metastatic breast cancer (HR+, HER2– mBC): Prevalence, biomarker characteristics, and outcomes.
 
Rinath Jeselsohn
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Carrick Therapeutics; GE Healthcare
Research Funding - Lilly (Inst); Pfizer (Inst)
 
Lu Chen
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Nayan Chaudhary
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Jorge Martinalbo
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Peter A. Fasching
Honoraria - Agendia; AstraZeneca; BionTech (Inst); Cepheid (Inst); Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst); Roche
 
Marc Hafner
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Patricia Luhn
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Alberto J. Montero
Honoraria - AstraZeneca; Celgene; OncoSec
Consulting or Advisory Role - New Century Health; Paragon healthcare; Welwaze
(OPTIONAL) Uncompensated Relationships - Roche
 
Pablo Diego Pérez-Moreno
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Seth Andrew Wander
Consulting or Advisory Role - Biovica; Foundation Medicine; Hologic; Lilly; Pfizer; Puma Biotechnology; Veracyte
Speakers' Bureau - Guardant Health; Lilly
Research Funding - Genentech; Lilly; Nuvation Bio; Pfizer; Regor Therapeutics
 
Kevin Kalinsky
Employment - EQRx (I); GRAIL (I)
Stock and Other Ownership Interests - EQRx (I); GRAIL (I)
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; immunomedics; Lilly; Menarini Silicon Biosystems; Merck; mersana; Myovant Sciences; Novartis; Oncosec; Prelude Therapeutics; Puma Biotechnology; Seagen; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
Other Relationship - Genentech; Immunomedics